Untreated AML
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation (NCT03173248) | Institut de Recherches Internationales Servier | 2017-06-26 |
| Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation (NCT02632708) | Institut de Recherches Internationales Servier | 2015-12-31 |
| Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation (NCT02074839) | Institut de Recherches Internationales Servier | 2014-03-01 |
Track Untreated AML automatically
Every clearance here is in the API, with alerts when new ones post.